Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Vitura Health.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX health stocks: Proteomics tumbles 22pc on delayed product launch, Race hits 10mth highs
Health & Biotech
Dr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weed
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
News
ASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, Philips
News
Closing Bell: Stocks putting out good news, sneaking in bad news while almost everyone watches the cricket
Health & Biotech
Weed Week: Jamaican nettletree could be a new, cheaper option to source CBD, says scientists
Health & Biotech
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
News
Market Highlights: Google surges while Snap Inc plunges, as Mizuho puts bet on AI stocks
News
ASX Small Caps Lunch Wrap: Who will your favourite company be voting for in the US elections?
Health & Biotech
Weed Week: A ‘shroom boom’ could see psychedelics follow cannabis’ explosive footsteps
Health & Biotech
Weed Week: New studies confirm cannabis alleviates cancer pain, cuts need for opioids, and improves sleep
News
Top 10 at 10: High grade gold hits and a big psychedelics joint venture
Health & Biotech
ASX Health Stocks: Emyria surges another 10pc; cannabis play Vitura delivers record profit
Health & Biotech
Weed Week: Codeine demand drops when recreational cannabis is legal, study finds
Experts
After scaring everyone in 2022 it looks like ASX health stocks will have a pulse in 2023
Health & Biotech
Weed Week: Aussie companies jostle to become the world’s supplier of medicinal cannabis
Health & Biotech